ACI Global Corp. (ACGJ)

[momo engine]

Aci Global Corp (ACGJ) Key Developments Pacgen Biopharmaceuticals Corporation Signs an Amendment to its License Agreement with ACI Global Corporation Jan 30 12 Pacgen Biopharmaceuticals Corporation announced that the company has signed an amendment to its license agreement with ACI Global Corporation to expand its exclusive worldwide rights and license to PAC-113 for additional indications, including vaginal, dermatological and ophthalmic applications. There was no payment associated with the amendment license agreement. All other terms of the license agreement remained unchanged. Pacgen has right to sublicense all these additional indications as well as oral indications covered in its original license.